The OraSure Family of Companies

OraSure Technologies, Inc. transforms health through actionable insight and powers the shift that connects people to healthcare wherever they are. OraSure improves access, quality, and value of healthcare with innovation in effortless tests and sample collection solutions. OraSure, together with its wholly-owned subsidiary, DNA Genotek, Inc., is a leader in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. Our portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, commercial entities, and direct to consumers.

Webinar: A Syndemic Approach to Syphilis, HIV and HCV Rapid Screening in Clinic & Outreach Settings

In this webinar hosted by the National Coalition of STD Directors (NCSD), you will hear about the value of rapid testing for syphilis, HIV and HCV. Learn more from urban and rural health departments with experience in outreach and community testing and gain key insights into implementation practices.

Interview: Rapid HIV and HCV Testing for Underserved Communities

Despite advances in medical treatment, people remain reluctant to get tested for infectious diseases like HIV and HCV, due to fears of a positive test or related stigma and discrimination.

Hear from Sandra Marrero-Ashford, Executive Director of the Health Betterment Initiative (HBI) as she explains their journey in using rapid testing for underserved communities and linking people to requisite care.